Accolade Inc
NASDAQ:ACCD

Watchlist Manager
Accolade Inc Logo
Accolade Inc
NASDAQ:ACCD
Watchlist
Price: 7.02 USD Market Closed
Market Cap: $575.6m

Accolade Inc
Stock-Based Compensation

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Accolade Inc
Stock-Based Compensation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Accolade Inc
NASDAQ:ACCD
Stock-Based Compensation
$52.3m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Stock-Based Compensation
$88m
CAGR 3-Years
5%
CAGR 5-Years
-2%
CAGR 10-Years
5%
CVS Health Corp
NYSE:CVS
Stock-Based Compensation
$535m
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
9%
Cigna Corp
NYSE:CI
Stock-Based Compensation
$291m
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
10%
Laboratory Corporation of America Holdings
NYSE:LH
Stock-Based Compensation
$125.8m
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
2%
Guardant Health Inc
NASDAQ:GH
Stock-Based Compensation
$166.2m
CAGR 3-Years
21%
CAGR 5-Years
3%
CAGR 10-Years
N/A
No Stocks Found

Accolade Inc
Glance View

Accolade, Inc. engages in the provision of personalized health and benefits solutions. The company is headquartered in Seattle, Washington and currently employs 2,350 full-time employees. The company went IPO on 2020-07-02. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The firm leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.

ACCD Intrinsic Value
8.24 USD
Undervaluation 15%
Intrinsic Value
Price $7.02

See Also

What is Accolade Inc's Stock-Based Compensation?
Stock-Based Compensation
52.3m USD

Based on the financial report for Nov 30, 2024, Accolade Inc's Stock-Based Compensation amounts to 52.3m USD.

What is Accolade Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 3Y
2%

Over the last year, the Stock-Based Compensation growth was -18%. The average annual Stock-Based Compensation growth rates for Accolade Inc have been 2% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett